ORIGINAL PAPER
Vitamin D status in children with migraine: a case-control study
1
Department of Pediatrics, Golestan Medical, Educational, and Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2
Department of Industrial Engineering, Islamic Azad University, Mahshahr, Iran
Submission date: 2020-09-20
Final revision date: 2020-10-27
Acceptance date: 2020-10-27
Publication date: 2021-01-30
Pediatr Pol 2020;95(4):228-233
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Vitamin D deficiency has been observed in patients with migraine; however, the results of previous studies are controversial. We aimed to evaluate vitamin D status in a group of children with migraine and to compare them with a group of healthy control.
Material and methods:
We conducted a prospective case-control study to assess the vitamin D status in children with migraine comparing them with age- and sex-matched healthy controls. Thirty children with migraine and 30 healthy controls were enrolled in the study. The age range was 6-14 years. The vitamin D status was classified as optimal (> 20 ng/ml), insufficient (11–20 ng/ml), and deficient (≤ 10 ng/ml). We also tried to assess the correlation between vitamin D status and the severity and frequency of headache attacks.
Results:
: In the migraine group, five patients (3 girls and 2 boys) had optimal vitamin D, 20 (10 girls and 10 boys) had insufficiency and five (4 girls and 1 boy) were deficient. In the control group, six patients (4 girls and 2 boys) had optimal vitamin D, 19 (8 girls and 11 boys) had insufficiency, and five (4 girls and 1 boy) were deficient. Vitamin D status had no significant difference between groups (p = 0.943). We could not find any correlation between vitamin D status and severity (Pearson correlation, p = 0.513) and frequency (Pearson correlation, p = 0.422) of migraine attacks.
Conclusions:
Vitamin D insufficiency and deficiency are equally common in children with migraine and healthy controls. We need well designed case control studies with large sample sizes to properly assess the probable pathophysiologic role of vitamin D in children with migraine.
Vitamin D deficiency has been observed in patients with migraine; however, the results of previous studies are controversial. We aimed to evaluate vitamin D status in a group of children with migraine and to compare them with a group of healthy control.
Material and methods:
We conducted a prospective case-control study to assess the vitamin D status in children with migraine comparing them with age- and sex-matched healthy controls. Thirty children with migraine and 30 healthy controls were enrolled in the study. The age range was 6-14 years. The vitamin D status was classified as optimal (> 20 ng/ml), insufficient (11–20 ng/ml), and deficient (≤ 10 ng/ml). We also tried to assess the correlation between vitamin D status and the severity and frequency of headache attacks.
Results:
: In the migraine group, five patients (3 girls and 2 boys) had optimal vitamin D, 20 (10 girls and 10 boys) had insufficiency and five (4 girls and 1 boy) were deficient. In the control group, six patients (4 girls and 2 boys) had optimal vitamin D, 19 (8 girls and 11 boys) had insufficiency, and five (4 girls and 1 boy) were deficient. Vitamin D status had no significant difference between groups (p = 0.943). We could not find any correlation between vitamin D status and severity (Pearson correlation, p = 0.513) and frequency (Pearson correlation, p = 0.422) of migraine attacks.
Conclusions:
Vitamin D insufficiency and deficiency are equally common in children with migraine and healthy controls. We need well designed case control studies with large sample sizes to properly assess the probable pathophysiologic role of vitamin D in children with migraine.
REFERENCES (38)
2.
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd ed. Cephalalgia 2018; 38: 1-211.
3.
El-Chammas K, Keyes J, Thompson N, Vijayakumar J, Becher D, Jackson JL. Pharmacologic treatment of pediatric headaches: a meta-analysis. JAMA Pediatr 2013; 167: 250-258.
4.
Liampas I, Siokas V, Brotis A, Dardiotis E. Vitamin D serum levels in patients with migraine: A meta-analysis. Rev Neurol (Paris) 2020; 176: 560-570.
5.
Liampas I, Siokas V, Brotis A, Vikelis M, Dardiotis E. Endogenous melatonin levels and therapeutic use of exogenous melatonin in migraine: systematic review and meta-analysis. Headache 2020; 60: 1273-1299.
6.
Liampas I, Siokas V, Mentis AA, Aloizou AM, Dastamani M, Tsouris Z, et al. Serum homocysteine, pyridoxine, folate, and vitamin B12 levels in migraine: systematic review and meta-analysis. Headache 2020; 60: 1508-1534.
7.
Liampas IN, Siokas V, Aloizou AM, Tsouris Z, Dastamani M, Aslanidou P, et al. Pyridoxine, folate and cobalamin for migraine: a systematic review. Acta Neurol Scand 2020; 142: 108-120.
8.
Nowaczewska M, Wicinski M, Osinski S, Kazmierczak H. The role of vitamin d in primary headache-from potential mechanism to treatment. Nutrients 2020; 12: 243.
9.
Buettner C, Burstein R. Association of statin use and risk for severe headache or migraine by serum vitamin D status: a cross-sectional population-based study. Cephalalgia 2015; 35: 757-766.
10.
Buettner C, Nir RR, Bertisch SM, Bernstein C, Schain A, Mittleman MA, et al. Simvastatin and vitamin D for migraine prevention: a randomized, controlled trial. Ann Neurol 2015; 78: 970-981.
11.
Cayir A, Turan MI, Tan H. Effect of vitamin D therapy in addition to amitriptyline on migraine attacks in pediatric patients. Braz J Med Biol Res 2014; 47: 349-354.
12.
Donmez A, Orun E, Sonmez FM. Vitamin D status in children with headache: a case-control study. Clin Nutr ESPEN 2018; 23: 222-227.
13.
Gazerani P, Fuglsang R, Pedersen JG, Sorensen J, Kjeldsen JL, Yassin H, et al. A randomized, double-blinded, placebo-controlled, parallel trial of vitamin D3 supplementation in adult patients with migraine. Curr Med Res Opin 2019; 35: 715-723.
14.
Ghorbani Z, Rafiee P, Fotouhi A, Haghighi S, Rasekh Magham R, Ahmadi ZS, et al. The effects of vitamin D supplementation on interictal serum levels of calcitonin gene-related peptide (CGRP) in episodic migraine patients: post hoc analysis of a randomized double-blind placebo-controlled trial. J Headache Pain 2020; 21: 22.
15.
Hanci F, Kabakus N, Turay S, Bala KA, Dilek M. The role of obesity and vitamin D deficiency in primary headaches in childhood. Acta Neurol Belg 2020; 120: 1123-1131.
16.
Knutsen KV, Madar AA, Brekke M, Meyer HE, Natvig B, Mdala I, et al. Effect of vitamin D on musculoskeletal pain and headache: a randomized, double-blind, placebo-controlled trial among adult ethnic minorities in Norway. Pain 2014; 155: 2591-2598.
17.
Mottaghi T, Khorvash F, Askari G, Maracy MR, Ghiasvand R, Maghsoudi Z, et al. The relationship between serum levels of vitamin D and migraine. J Res Med Sci 2013; 18: S66-70.
18.
Prakash S, Kumar M, Belani P, Susvirkar A, Ahuja S. Interrelationships between chronic tension-type headache, musculoskeletal pain, and vitamin D deficiency: is osteomalacia responsible for both headache and musculoskeletal pain? Ann Indian Acad Neurol 2013; 16: 650-658.
19.
Prakash S, Rathore C, Makwana P, Dave A, Joshi H, Parekh H. Vitamin D deficiency in patients with chronic tension-type headache: a case-control study. Headache 2017; 57: 1096-1108.
20.
Rapisarda L, Mazza MR, Tosto F, Gambardella A, Bono F, Sarica A. Relationship between severity of migraine and vitamin D deficiency: a case-control study. Neurol Sci 2018; 39: 167-168.
21.
Song TJ, Chu MK, Sohn JH, Ahn HY, Lee SH, Cho SJ. Effect of vitamin D deficiency on the frequency of headaches in migraine. J Clin Neurol 2018; 14: 366-373.
22.
Togha M, Razeghi Jahromi S, Ghorbani Z, Martami F, Seifishahpar M. Serum vitamin D status in a group of migraine patients compared with healthy controls: a case-control study. Headache 2018; 58: 1530-1540.
23.
Tozzi E, Boncristiano A, Antenucci A, Di Loreto S, Farello G. P013. 25(OH)D level and headache in children sample. J Headache Pain 2015; 16: A84.
24.
Zandifar A, Masjedi SS, Banihashemi M, Asgari F, Manouchehri N, Ebrahimi H, et al. Vitamin D status in migraine patients: a case- control study. Biomed Res Int 2014; 2014: 514782.
25.
Burstein R, Noseda R, Borsook D. Migraine: multiple processes, complex pathophysiology. J Neurosci 2015; 35: 6619-6629.
26.
Mottaghi T, Askari G, Khorvash F, Maracy MR. Effect of Vitamin D supplementation on symptoms and C-reactive protein in migraine patients. J Res Med Sci 2015; 20: 477-482.
27.
Kenis-Coskun O, Giray E, Gunduz OH, Akyuz G. The effect of vitamin D replacement on spinal inhibitory pathways in women with chronic widespread pain. J Steroid Biochem Mol Biol 2020; 196: 105488.
28.
Kirkland AE, Sarlo GL, Holton KF. The role of magnesium in neurological disorders. Nutrients 2018; 10: 730.
29.
Messlinger K, Lennerz JK, Eberhardt M, Fischer MJ. CGRP and NO in the trigeminal system: mechanisms and role in headache generation. Headache 2012; 52: 1411-1427.
30.
Goadsby PJ, Holland PR. An update: pathophysiology of migraine. Neurol Clin 2019; 37: 651-671.
31.
Sohn JH, Chu MK, Park KY, Ahn HY, Cho SJ. Vitamin D deficiency in patients with cluster headache: a preliminary study. J Headache Pain 2018; 19: 54.
33.
Wong DL, Baker CM. Pain in children: comparison of assessment scales. Pediatr Nurs 1988; 14: 9-17.
34.
Mittal S, Sharma A, Sharma A, Gupta K, Gaur A, Pathania V. Banded versus single-sided bonded space maintainers: a comparative study. Indian Journal of Dental Sciences 2018; 10: 29-36.
35.
Buse DC, Manack A, Serrano D, Turkel C, Lipton RB. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry 2010; 81: 428-432.
36.
Yin P, Anttila V, Siewert KM, Palotie A, Davey Smith G, Voight BF. Serum calcium and risk of migraine: a Mendelian randomization study. Hum Mol Genet 2017; 26: 820-828.
37.
Jazayeri M, Moradi Y, Rasti A, Nakhjavani M, Kamali M, Barada-ran HR. Prevalence of vitamin D deficiency in healthy Iranian children: a systematic review and meta-analysis. Med J Islam Repub Iran 2018; 32: 83.
38.
Mellati AA, Sharifi F, Faghihzade S, Mousaviviri SA, Chiti H, Kazemi SA. Vitamin D status and its associations with components of metabolic syndrome in healthy children. J Pediatr Endocrinol Metab 2015; 28: 641-648.
Share
RELATED ARTICLE
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
